Ultragenyx Pharmaceutical Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| UP0.F | DSGN | IDIA.SW | PHAR | IVA | BBIO | |
|---|---|---|---|---|---|---|
| Market cap | 1.49B | 665.24M | 1.17B | 881.90M | 914.17M | 15.17B |
| P/E (TTM) | — | — | — | 38.9 | — | — |
| Forward P/E | -2.6 | -6.6 | 78.2 | 69.2 | -5.2 | -225.0 |
| Price/book | -5.7 | 3.0 | -0.9 | 2.9 | 13.8 | -5.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −47.02% | +54.73% | +33.64% | −15.24% | −7.42% | +24.17% |
| Today | +8.86% | +2.80% | −1.95% | −3.63% | −3.97% | +5.21% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All UP0.F news ›Ultragenyx Pharmaceutical Inc. (RARE) Q3 2026 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. (RARE) Q3 2026 Earnings Call November 3, 2026 5:00 PM EST Joshua Higa - Director of Investor Relations & Corporate CommunicationsEmil Kakkis - Founder, President, CEO & DirectorHoward Horn - Executive VP of…
Ultragenyx Pharmaceutical (RARE) Set to Post Quarterly Earnings on Tuesday
Posted by Danessa Lincoln on Oct 27th, 2026 Shares of RARE opened at $16.08 on Tuesday. The company has a 50 day moving average price of $17.74 and a 200-day moving average price of $23.03. Ultragenyx Pharmaceutical has a fifty-two week…
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Average Target Price of $33.65
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has been assigned an average rating of “Hold” from the twenty-two brokerages that are currently covering the stock, MarketBeat.com reports.
Ultragenyx Pharmaceutical Inc. $RARE Stock Acquired by Assenagon Asset Management S.A.
MarketBeat Ultragenyx Pharmaceutical Inc. $RARE Stock Acquired by Assenagon Asset Management S.A. Assenagon Asset Management S.A. boosted its holdings in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report)
Madison Avenue International LP Reports 6.4% Stake in Ultragenyx Pharmaceutical Inc.
Pegasystems (NASDAQ:PEGA) Missed, Yet Rallied: What’s Going On? Is Goldman Sachs (NYSE:GS) Benefiting From Capital Markets Activity? On October 20, 2026, a Schedule 13G filing revealed that Madison Avenue International LP along with…
Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Howard Horn Sells 7,066 Shares of Company Stock
Posted by Defense World Staff on Oct 20th, 2026 Shares of Ultragenyx Pharmaceutical stock opened at $15.07 on Tuesday. Ultragenyx Pharmaceutical Inc. has a 12 month low of $12.73 and a 12 month high of $39.89. The business’s 50-day moving…
Ultragenyx Pharmaceutical agrees to US$203M priority review voucher sale
Cash is payable at closing, subject to antitrust conditions; two announced voucher agreements total US$413 million. In the United States, a rare pediatric disease priority review voucher sale announced Wednesday carries a US$203 million…
Lobbying Update: $280,000 of ULTRAGENYX PHARMACEUTICAL INC. lobbying was just disclosed
$280,000 of ULTRAGENYX PHARMACEUTICAL INC. lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. "Issues related to drug development, access and reimbursement for rare and ultra rare diseases. Issues…
Ultragenyx Pharmaceutical (RARE) Sells $203M Priority Review Voucher Amid Gene Therapy Advances
On October 14, 2026, Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) announced a $203 million agreement to sell a priority review voucher tied to the FDA approval of its gene therapy Fayuvi, targeting Sanfilippo syndrome type A in children.…
Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Purchase Disclosed by Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). In a filing disclosed on October 12th, the Representative disclosed that they had bought between…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com11
- marketbeat.com3
- mugglehead.com2
- themarketsdaily.com2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.